PharmaEssentia to Open Puerto Rico Plant in 2027, Expanding Global Ropeg Reach
The board of directors of PharmaEssentia Corp. resolved this year to invest $46 million to construct a brand-new pharmaceutical manufacturing plant in Puer
The board of directors of PharmaEssentia Corp. resolved this year to invest $46 million to construct a brand-new pharmaceutical manufacturing plant in Puerto Rico, which is expected to begin operations in 2027. This move aligns with the company’s completion earlier this year of a $36.5 million full acquisition of a Canadian pharmaceutical firm. Together
Produced by our editorial team, with AI assistance in editing.